Although respiratory failure and hypoxaemia are the main manifestations of COVID-19,
kidney involvement is also common. Available evidence supports a number of potential …

The vast majority of patients (> 99%) with severe acute respiratory syndrome coronavirus 2
survive immediate infection but remain at risk for persistent and/or delayed multisystem. This …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can lead to
postacute sequelae in multiple organ systems, but evidence is mostly limited to the first year …

The neurologic manifestations of acute COVID-19 are well characterized, but a
comprehensive evaluation of postacute neurologic sequelae at 1 year has not been …

The post-acute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection—also referred to as Long COVID—have been described, but whether …

Background There is growing evidence suggesting that beyond the acute phase of SARS-
CoV-2 infection, people with COVID-19 could experience a wide range of post-acute …

The cardiovascular complications of acute coronavirus disease 2019 (COVID-19) are well
described, but the post-acute cardiovascular manifestations of COVID-19 have not yet been …

Importance Post–COVID-19 condition (PCC), also known as long COVID, affects many
individuals. Prevention of PCC is an urgent public health priority. Objective To examine …

The acute clinical manifestations of COVID-19 have been well characterized,, but the post-
acute sequelae of this disease have not been comprehensively described. Here we use the …

Abstract The Post-Acute Sequelae of SARS-CoV-2 infection (PASC) have been
characterized; however, the burden of PASC remains unknown. Here we used the …